2008Sichuan Mental HealthRequires access

A study of efficacy of depakin combined with lithium carbonate in the treatment of manic episode of bipolar disorder

Xia Zhou

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy and safety of depakin combined with lithium carbonate in treating manic episodes of bipolar disorder.Methods 74 patients were ramdomly divided into two groups,depakin combined with lithium carbonate group(group A)(n=37)or lithium carbonate group(group B)(n=37).They were treated for 8 weeks.The patients were evaluated with the Bech-Rafaelsen Mania Rating Scale and and TESS before treatment and on 1st,2nd,4th and 8th weekend after treatment.Results The clinical response rates were 83.8% in group A and 81.1% in group B.There was no significant difference between two groups(χ2=0.093,P0.05).There was significantly lower rate of side effects in group A(8.1%)than that in group B(29.7%)(χ2=5.638,P0.05).Conclusion Depakin combined with lithium carbonate has similar therapeutic effect to lithium carbonate alone in the treatment of manic episodes,and has better tolerability.

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of depakin combined with lithium carbonate in treating manic episodes of bipolar disorder.Methods 74 patients were ramdomly divided into two groups,depakin combined with lithium carbonate group(group A)(n=37)or lithium carbonate group(group B)(n=37).They were treated for 8 weeks.The patients were evaluated with the Bech-Rafaelsen Mania Rating Scale and and TESS before treatment and on 1st,2nd,4th and 8th weekend after treatment.Results The clinical response rates were 83.8% in group A and 81.1% in group B.There was no significant difference between two groups(χ2=0.093,P0.05).There was significantly lower rate of side effects in group A(8.1%)than that in group B(29.7%)(χ2=5.638,P0.05).Conclusion Depakin combined with lithium carbonate has similar therapeutic effect to lithium carbonate alone in the treatment of manic episodes,and has better tolerability.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of depakin combined with lithium carbonate in treating manic episodes of bipolar disorder.Methods 74 patients were ramdomly divided into two groups,depakin combined with lithium carbonate group(group A)(n=37)or lithium carbonate group(group B)(n=37).They were treated for 8 weeks.The patients were evaluated with the Bech-Rafaelsen Mania Rating Scale and and TESS before treatment and on 1st,2nd,4th and 8th weekend after treatment.Results The clinical response rates were 83.8% in group A and 81.1% in group B.There was no significant difference between two groups(χ2=0.093,P0.05).There was significantly lower rate of side effects in group A(8.1%)than that in group B(29.7%)(χ2=5.638,P0.05).Conclusion Depakin combined with lithium carbonate has similar therapeutic effect to lithium carbonate alone in the treatment of manic episodes,and has better tolerability.

Key concepts: Lithium carbonate, Tolerability, Mania, Bipolar disorder, Lithium (medication), Carbonate, Internal medicine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A study of efficacy of depakin combined with lithium carbonate in the treatment of manic episode of bipolar disorder — Research Paper | ScholarLens